DiscoverLaboratory Considerations for Clinical TrialsFlexible Approaches for Biotech Companies in Clinical Trials
Flexible Approaches for Biotech Companies in Clinical Trials

Flexible Approaches for Biotech Companies in Clinical Trials

Update: 2022-06-22
Share

Description

With fewer people covering more roles with less specialization and novel therapeutics with unique testing requirements, the needs of small biotech companies in clinical trials are different from larger sponsors.


In this episode, Alex Watt, Global Head for Biotech Integrated Laboratory Solutions and Mona Henderson, Director of Laboratory Network Solutions (both at Q2 Solutions) discuss how our dedicated biotech teams focus specifically on the unique needs of those customers.


Alex and Mona cover:


  • Operational strategy, from supply chain to data management

  • The role of LNS in contracting and managing specialty, third-party labs

  • Collaboration with our parent company, IQVIA and

  • Adapting to evolving customer strategies 


You can learn more at https://q2labsolutions.com/biotech.


 

Comments 
loading
00:00
00:00
1.0x

0.5x

0.8x

1.0x

1.25x

1.5x

2.0x

3.0x

Sleep Timer

Off

End of Episode

5 Minutes

10 Minutes

15 Minutes

30 Minutes

45 Minutes

60 Minutes

120 Minutes

Flexible Approaches for Biotech Companies in Clinical Trials

Flexible Approaches for Biotech Companies in Clinical Trials

Q Squared Solutions